“Diagnostics startup Blueprint Genetics puts expansion to the test” / Tekes

Published on November 15, 2015

“After establishing an office in the USA, business is set to grow tenfold for this genetic testing company in the near future.

The road to success for startups is one that is typically paved with various twists and turns. Whilst a company may start out with an original idea, in time circumstances often dictate a sharp lurch into unexpected territory. Sometimes further tweaks are still needed to the business model before a successful approach is found. Not so for diagnostics company Blueprint Genetics…”

Read more in the article by James O’Sullivan, published by Tekes

https://www.tekes.fi/en/tekes/results-and-impact/cases1/2015/diagnostics-startup-blueprint-genetics-puts-expansion-to-the-test/

Last modified: 11.15.2015

News

New in Immunology: Primary Immunodeficiency / Primary Ciliary Dyskinesia Panel

Published on June 12, 2018

The aim of the new panel is to increase the clinical utility and diagnostic yield for patients with a clinical suspicion of primary immunodeficiency (PID), especially for those patients where primary ciliary dyskinesia (PCD) is included in the differential diagnosis. In these cases, the core symptoms are often very similar…

Read more

Subscribe to our newsletter